News from us and our partners

Tags

Topics

0 results

News
17 July, 2026
Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline
News
16 July, 2026
Mane expands partnership with Arzeda to accelerate commercialization of Vialeaf™ REB M
News
15 July, 2026
Latent Labs Launches Latent-Y to Researchers Worldwide — With Free Daily Access and On-Demand Credits for Larger Campaigns
News
14 July, 2026
Elevara Medicines appoints biotech veteran as CEO
News
13 July, 2026
Sofinnova Partners appoints David Evans as Partner
News
13 July, 2026
Tenpoint Therapeutics announces United Kingdom submission of marketing authorization application for YUVEZZI™ treatment of Presbyopia in adults
News
8 July, 2026
Inventiva Strengthens Board of Directors with Appointment of Three Distinguished Life Sciences Leaders
News
8 July, 2026
Seven years: the journey behind Myricx's acquisition by Novartis
News
8 July, 2026
Abivax Announces Closing of $920 Million Public Offering
News
8 July, 2026
Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia
News
6 July, 2026
Sofinnova Partners announces Myricx Bio agrees to be acquired by Novartis
News
6 July, 2026
AFYREN announces the resumption of production at its plant after the successful technical shutdown
News
2 July, 2026
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
News
1 July, 2026
Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
News
30 June, 2026
Biotalys Announces Retirement of Board Member Patrick Van Beneden
News
30 June, 2026
DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences.

Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline

Mane expands partnership with Arzeda to accelerate commercialization of Vialeaf™ REB M

Latent Labs Launches Latent-Y to Researchers Worldwide — With Free Daily Access and On-Demand Credits for Larger Campaigns

Elevara Medicines appoints biotech veteran as CEO

Sofinnova Partners appoints David Evans as Partner

Tenpoint Therapeutics announces United Kingdom submission of marketing authorization application for YUVEZZI™ treatment of Presbyopia in adults

Inventiva Strengthens Board of Directors with Appointment of Three Distinguished Life Sciences Leaders

Seven years: the journey behind Myricx's acquisition by Novartis

Abivax Announces Closing of $920 Million Public Offering

Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia

Sofinnova Partners announces Myricx Bio agrees to be acquired by Novartis

AFYREN announces the resumption of production at its plant after the successful technical shutdown

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Biotalys Announces Retirement of Board Member Patrick Van Beneden

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences.